Delivery Order SPE2DB20D9331-SPE2DB24FL1P5

Award Date 8/13/24
Potential Completion Date 9/4/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $446,699.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product, to support the medical supply needs of U.S. military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/ml syringes and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which covers a wide range of pharmaceutical products including branded and generic prescription drugs,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $37,137.60 contract is for the provision of Xolair 150 mg/1.2 ml powder vials, a specialty biologic medication. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a comprehensive portfolio of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Xolair 150 mg/ml syringes and is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a $30,948.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $37,224.96 firm fixed-price delivery order for the supply of Xolair 150 mg/1.2 ml powder vials, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $20,116.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,868.50 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a completion date of January 7, 2025. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, enabling...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/1.2 ml powder for injection. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB20D9761, a $4,999,999 single-award contract with DLA that enables the agency to issue delivery orders...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1P5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/1.2 ml powder vials, which are used to treat respiratory conditions.

This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders to DMS for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's status as a woman-owned small business helps it secure these direct federal contract awards. The current delivery order has no set-aside designation.

Generated 1/9/25, 9:20 AM